TheScreener - Adocia SA (ADOC) ADOCIA reduced its risk exposure resulting in an upgrade to Slightly Positive

Report

TheScreener

EUR 12.95 For Business Accounts Only

ADOCIA reduced its risk exposure resulting in an upgrade to Slightly Positive

ADOCIA (FR), a company active in the Biotechnology industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date October 29, 2021, the closing price was EUR 9.00 and its potential was estimated at EUR 11.36.

30/10/2021 6 EN

Underlying

Adocia SA

ADOCIA is a biotechnology company based in France. Co. specializes in the development of formulations for already-approved therapeutic proteins with a primary focus on insulins and treatments for diabetic foot ulcers. Co.'s biotherapy products are used in tissue regeneration and for treating chronic diseases. Co.'s proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins in areas such as wound Healing, diabetes, ulcers and monoclonal antibody creation. Co. also maintains activities in the formulation of monoclonal antibodies for the treatment of various chronic pathologies (oncology, inflammation, etc.).

See profile

FR0011184241 Euronext Paris France

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

BusinessWire

ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 28 février 2025

LYON, France--(BUSINESS WIRE)-- Regulatory News: Conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers (« AMF »), ADOCIA SA (Paris:ADOC), 115, avenue Lacassagne, 69003 Lyon (Euronext Paris : FR0011184241 – ADOC – la « Société »), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques innovantes pour le traitement du diabète et de l’obésité, publie le nombre d’actions composant son capital social ainsi que le nombre de droits de...

March 14, 2025 March 14, 2025 1 FR

BusinessWire

ADOCIA annonce le règlement-livraison de son placement privé de 9,7 millions d'euros

LYON, France--(BUSINESS WIRE)-- Regulatory News: NE PAS DIFFUSER DIRECTEMENT OU INDIRECTEMENT AUX ETATS-UNIS D'AMERIQUE, AU CANADA, EN AUSTRALIE, AU JAPON OU EN AFRIQUE DU SUD Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans le développement de formulations innovantes pour le traitement du diabète et de l’obésité (la « Société »), annonce aujourd’hui le règlement-livraison de son placement privé d'un montant de 9 732 500 euros (incluant la prime d’émission) réalisé par voie d'émission, sans droit préférentiel de souscription, de 2 ...

February 28, 2025 February 28, 2025 1 FR

BusinessWire

ADOCIA annonce la réalisation d’un placement privé de 9,7 millions d’euros, prolongeant sa trésorerie jusqu'au deuxième trimestre 2026

LYON, France--(BUSINESS WIRE)-- Regulatory News: NE PAS DIFFUSER DIRECTEMENT OU INDIRECTEMENT AUX ETATS-UNIS D'AMERIQUE, AU CANADA, EN AUSTRALIE, AU JAPON OU EN AFRIQUE DU SUD Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans le développement de formulations innovantes pour le traitement du diabète et de l’obésité (la « Société »), annonce aujourd’hui la réalisation d’une augmentation de capital d’un montant total brut de 9 732 500 millions d’euros, souscrite par un nombre limité d’investisseurs, dont Armistice Capital (pour 7 milli...

February 26, 2025 February 26, 2025 1 FR

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

ADOCIA reduced its risk exposure resulting in an upgrade to Slightly Positive

Empowering Investors

ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 28 février 2025

ADOCIA annonce le règlement-livraison de son placement privé de 9,7 millions d'euros

ADOCIA annonce la réalisation d’un placement privé de 9,7 millions d’euros, prolongeant sa trésorerie jusqu'au deuxième trimestre 2026

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe